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A sensitive and specific liquid chromatography-mass spectrometry (LC-MS) method based on
the combination of constant neutral loss scans (CNL) with product ion scans was developed on
a linear ion trap. The method is applicable for the detection and identification of analytes with
identical chemical substructures (such as conjugates of xenobiotics formed in biological
systems) which give common CNLs. A specific CNL was observed for thioethers of
N-acetyl-L-cysteine (mercapturic acids, MA) by LC-MS/MS. MS and HPLC parameters were
optimized with 16 MAs available as reference compounds. All of these provided a CNL of 129
Da in the negative-ion mode. To assess sensitivity, a multiple reaction monitoring (MRM)
mode with 251 theoretical transitions using the CNL of 129 Da combined with a product ion
scan (IDA thMRM) was compared with CNL combined with a product ion scan (IDA CNL).
An information-dependent acquisition (IDA) uses a survey scan such as MRM (multiple
reaction monitoring) to generate “informations” and starting a second acquisition experiment
such as a product ion scan using these “informations.” Th-MRM means calculated transitions
and not transitions generated from an available standard in the tuning mode. The product ion
spectra provide additional information on the chemical structure of the unknown analytes. All
MA standards were spiked in low concentrations to rat urines and were detected with both
methods with LODs ranging from 60 pmol/mL to 1.63 nmol/mL with IDA thMRM. The
expected product ion spectra were observed in urine. Application of this screening method to
biological samples indicated the presence of a number of MAs in urine of unexposed rats, and
resulted in the identification of 1,4-dihydroxynonene mercapturic acid as one of these MAs by
negative and positive product ion spectra. These results show that the developed methods
have a high potential to serve as both a prescreen to detect unknownMAs and to identify these
analytes in complex matrix. (J Am Soc Mass Spectrom 2005, 16, 1976–1984) © 2005 American
Society for Mass SpectrometryThe determination of metabolites of xenobiotics,which may serve as biomarkers of exposure, inblood and urine of humans is an analytical chal-
lenge since humans may be exposed to a variety of
compounds at low concentrations [1]. Therefore, ana-
lytical methods have to be developed to screen blood or
urine samples for unknown chemicals or known drugs
and their metabolites for compound identification to
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doi:10.1016/j.jasms.2005.08.003calculate ultimate exposure levels [2]. Over recent years,
tandem LC-MS/MS has been extensively applied to
quantify compounds with known structures using tran-
sitions for the sensitive multiple reaction monitoring
(MRM) methods [3].
Many LC-MS/MS methods to determine specific
metabolites of xenobiotics have been described [4].
These hydrophilic analytes are well ionized by electro-
spray. However, the compound-specific methods do
not permit screening for compounds with unknown
structures such as metabolites, and synthetic reference
materials are necessary to develop a sensitive MRM
method in complex matrices [5– 8]. Metabolite stan-
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in the full scan mode is difficult owing to the limited
sensitivity and specificity in complex matrices. There-
fore, the aim was to develop a screening method to
detect unknown compounds that carry identical sub-
structures. This approach permits the preselection of an
analyte group [9]. The preselection criterion may be a
specific product ion such as m/z 113 in glucuronides,
[10] a specific neutral loss such as 162 Da involving a
glucose substructure as present in glycosides [9], or the
neutral loss of 129 Da of glutathione metabolites [11].
The choice of transition determines the choice of the
survey scan mode. With a conventional tandem MS, a
product ion scan can only be performed in a second
chromatographic separation and, in addition, the in-
strument is less sensitive than ion trap instruments [12,
13]. Therefore, the combination of a tandem mass
spectrometer and a sensitive ion trap in a single instru-
ment is the instrument of choice for precursor ion scan
(PreIS) or CNL combined with the acquisition of prod-
uct ion mass spectra [14, 15].
The new generation of linear ion traps offers the
possibility to combine CNL, PreIS, or MRM with a
product ion scan on a linear ion trap to acquire a mass
spectrum of every signal detected within one single
separation, since the third quadrupole is constructed as
an ion trap [16]. In addition to the specificity of the
survey scans, the product ion spectrum provides addi-
tional data to elucidate the structure of unknowns or to
confirm known analytes [17]. Glucuronic acid or sulfu-
ric acid conjugates and mercapturic acids (MAs) are
prominent metabolites of xenobiotics formed by bio-
transformation. MAs are formed by reaction of electro-
philes with glutathione and are eliminated in urine after
transpeptidase cleavage [18]. Due to the possible pres-
ence of many glucuronides, sulfates, and mercapturic
acids in the complex matrix, the availability of addi-
tional spectral information is important. Moreover, iso-
baric compounds may give false-positive results. In this
study, standards of mercapturic acids were analyzed
for characteristic product ions to generate specific CNL
or PreIS scans. In addition, theoretical MRM transitions
(thMRM) were generated using the CNL observed to
compare sensitivity to the IDA CNL method. For MRM,
CNL, thMRM, and the corresponding IDA methods,
sensitivity and specificity were compared and applied
to biological samples from experiments to generate
MAs under different conditions.
Materials and Methods
Chemicals
Unless otherwise noted, all chemicals were purchased
from Sigma/Aldrich (Taufkirchen, Germany) and were
of the highest purity available. N-acetyl-(2,2-
dichlorovinyl)-L-cysteine, N-acetyl-(1,2-dichlorovinyl)-
L-cysteine, N-acetyl-(4-chlorobenzyl)-L-cysteine,
N-acetyl-(2-fluorobenzyl)-L-cysteine, N-acetyl-(4-bromobenzyl)-L-cysteine, N-acetyl-(4-methoxybenzyl)-
L-cysteine, N-acetyl-(4-tert-butylbenzyl)-L-cysteine,
N-acetyl-(1,1-dichloro-2,2-difluoroethyl)-L-cysteine
[19], N-acetyl-(1,2,2-trichlorovinyl)-L-cysteine, N-acetyl-
(3-chloropropenyl)-L-cysteine, and N-acetyl-S-purinyl-
L-cysteine were synthesized and characterized as de-
scribed previously [20, 21]. N-acetyl-3-OH-propyl-L-
cysteine, N-acetyl-phenyl-L-cysteine, and N-acetyl-(2,4-
dinitrophenyl)-L-cysteine were obtained from Toronto
Research Chemicals (North York, Canada). 3-(N-
acetylcystein-S-yl)-acetaminophen, 3-N-acetyl-(1,4-
dihydroxynonenyl)-L-cysteine [22], and rat liver micro-
somes were kindly supplied by F. Hoffmann-La Roche
(Basel, Switzerland).
Synthesis of N-Acetyl-S-(2-Carbamoylethyl)-L-Cysteine
This adduct was synthesized according to the N-acetyl-
3-oxopropyl-L-cysteine synthesis of Ramu et al. [23]
using acrylamide in place of acrolein and characterized
by comparison of recently published mass spectral data
[24].
Instrumentation
The HPLC system consisted of an Agilent quaternary
solvent pump and an Agilent Autosampler Series 1100
(Waldbronn, Germany). The MS/MS system consisted
of a TURBO-Ionspray source and a QTRAP mass spec-
trometer API 2000 (Applied Biosystems, Darmstadt,
Germany). The centrifuge used was an Eppendorf Cen-
trifuge 5415C (Hamburg, Germany). A Synergi polar
RP18 4  (150  2 mm i.d.), a Synergi hydro RP18 4 m
(150  2 mm i.d.) from Phenomenex (Aschaffenburg,
Germany), or a Reprosil Pur C18 Aq 5 m (150  2 mm
i.d.) from Dr. Maisch GmbH (Ammerbruch, Germany)
were used. The precolumn (C18 material, 3 mm i.d.)
was also purchased from Phenomenex.
Analytical Methods
Stock solutions of the MA standards (1 mg/mL in
MeOH) were diluted with water. MS parameters such
as declustering potential (DP) or collision energy (CE)
were optimized with the “quantitative optimization”
function of analyst 1.3.2 or 1.4 to generate a MRM
method optimized for the individual MA standard
method. This MRM method was used for the optimiza-
tion of the HPLC parameters like flow rate, solvents,
and gradient. All standards were directly introduced
into the TURBO-IonSpray source using 5 mM ammo-
nium acetate, pH 6.8, 5 mM ammonium formiate, pH 3,
or 0.1% formic acid as mobile phases. A syringe pump
provided a constant analyte flow into the LC eluent
(0.25 mL/min) by a T-connection. Optimal sensitivity
was obtained with ammonium acetate (5 mM, pH 6.8)
in the negative-ion mode. HPLC-separations were per-
formed with 5 mM ammonium acetate, pH 6.8 (Solvent
A) and acetonitrile (AcCN) (Solvent B) with a flow rate
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concentration of 8.3 g/mL each. A gradient with the
following conditions was used: initial conditions were
5% Solvent B followed by a linear gradient from 5 to
50% B in 16 min, then 50% B for 4 min, 50 to 100% B in
1 min, 100% B for 2 min, 100 to 5% B in 1 min, and
re-equilibration by 5% B for 6 min. All HPLC columns
tested showed good peak shapes and a sufficient sepa-
ration of the standards but different retention times.
CNL and Optimized MRM
Standards were scanned for the CNL of 129 Da in the
negative-ion mode with the following parameters:
source voltage, 4.2 kV; vaporizer temperature, 400 °C;
curtain gas, 30 psi; nebulizer gas, 45 psi; turbogas, 50
psi; CAD gas, medium. When using the positive-ion
mode, only the source voltage was changed to 5.5 kV.
The CNL method development consisted of four exper-
iments with various DPs and CEs: experiment 1, DP
50 V, CE 20 V; experiment 2, DP 30 V, CE 30 V;
experiment 3, DP 40 V, CE 40 V; experiment 4, 50
V, CE 40 V. Collision Entrance Potential (CEP) and
Collision Cell Exit Potential (CXP) were set to 10 V
and 2 V, respectively. Q1 resolution was set at “unit”,
Q3 resolution was set at “low”. Differences in MS
parameter settings are described in Table 1.
IDA CNL and IDA thMRM
Survey scans were performed with either a CNL of 129
Da (mass range of 251 Da) or thMRM with 251 theoret-
ical mass transitions, adapted to the expected mass
ranges. Pause between the mass ranges was set to 5
Table 1. Important MS parameters used for the detection of the
Method
Compound optimized MRM
N-acetyl-(1,2-dichlorovinyl)-L-cysteine
N-acetyl-(2,2-dichlorovinyl)-L-cysteine
N-acetyl-(4-chlorobenzyl)-L-cysteine
N-acetyl-(2-fluorobenzyl)-L-cysteine
N-acetyl-(3-hydroxypropyl)-L-cysteine
N-acetyl-(4-brombenzyl)-L-cysteine
N-acetyl-(4-methoxybenzyl)-L-cysteine
N-acetyl-(4-tert-butylbenzyl)-L-cysteine
3-(N-acetylcystein-S-yl)-acetaminophen
N-acetyl-(1,1-Dichloro-2,2-difluoroethyl)-L-cysteine
N-acetyl-phenyl-L-cysteine
N-acetyl-(2,4-dinitrophenyl)-L-cysteine
N-acetyl-(1,2,2-trichlorovinyl)-L-cysteine
N-acetyl-(3-chloropropenyl)-L-cysteine
N-acetyl-S-(2-carbamoylethyl)-L-cysteine
N-acetyl-(S-purinyl)-L-cysteine
IDA MRM (251 masses)
IDA CNL (251 masses)
CNL with four experiments
CNL with one experimentmsec in the CNL mode and 2 msec in the thMRMmode.The information-dependent acquisition experiments
were performed with the following settings: if signals in
the survey scan exceeded 500 cps, a product ion scan
was performed; if more than one signal was recorded at
the same time, the highest signal was selected. Former
target ions were then excluded for at least 40 s. The
mass tolerance was set to 250 mmu. Fragments formed
in the product ion scan were detected in the range
between m/z 50 and 500 with dynamic fill time, a scan
rate of 4000 u/s, and resolution of Q1 was set to unit.
Determination of LOD in Solvent and Biological
Matrix
For the determination of the LOD of the MAs with the
IDA methods, a mixture of 12 MA standards with
concentrations of 0.04, 0.08, 0.16, 0.2, 0.4, 0.8, 1.6, and 4.2
g/mL of the individual analytes was diluted 1:2 with
either urine, incubation medium, or MeOH/H2O
(50/50 vol/vol). N-acetyl-(4-methoxybenzyl)-L-cysteine
(10 g/mL) was used as the internal standard. Urine
was collected from Wistar rats housed in Macrolon
cages [6]. Urinary proteins were precipitated by adding
AcCN (0 °C) to the urine sample (50/50 vol/vol) fol-
lowed by centrifugation at 15,000  g for 20 min. The
supernatant was removed and the procedure was re-
peated. The organic phase was removed under a stream
of nitrogen. Incubation solutions were prepared as
described below for controls. After 30 min of incubation
at 37 °C, the standard mixture was added. The sample
preparation used for the incubation media was identical
to that described for urine samples. Aliquots of each
sample (5 L) were analyzed with the IDA CNL and the
dards in the negative-ion mode
[V] used CE [V] used Dwelltime [ms]
DP CE
31 12 1000
51 20 1000
56 16 1000
41 20 1000
71 20 1000
51 24 1000
76 22 1000
76 26 1000
56 20 1000
61 16 1000
71 22 1000
26 16 1000
51 8 1000
66 20 1000
41 28 1000
21 24 1000
50 20 5
50 20 3000
50 20 each exp.: 1000
50 20 3000stan
DPIDA thMRM method (n  5). The LOD was defined as
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least three out of five product ion scans and showing a
signal with a CNL of 129 Da and S/N (signal to noise)
ratio of the corresponding peak heights of three.
Incubations with Diclofenac
Diclofenac was incubated at 37 °C for 60 min in a
shaking water bath with liver microsomal proteins
from rats. Incubation volume was 500 L and con-
sisted of 0.1 M potassium phosphate buffer (pH 7.4),
1 mM magnesium chloride, 10 mM glucose-6-phos-
phate, 1 mM NADP, 0.5 U/mL glucose-6-phosphate-
dehydrogenase, protein (1 mg/mL), and 10 mM
N-acetyl-L-cysteine (N-acys). Diclofenac (final con-
centration of 50 M or 100 M) was added after 5 min
of preincubation. Incubations without substrate
served as controls. Reactions were terminated by the
addition of AcCN (500 L). After centrifugation, the
supernatant was removed, and again 500 L of cold
AcCN was added. The mixture was centrifuged and
the organic phase was removed by a stream of
nitrogen. Aliquots (50 L) were injected into the
LC-MS/MS system. For the metabolism assay, the
mass range used was adapted to the expected molec-
ular masses of m/z 472 with a scan from m/z 250 to
500. Samples were injected three times with each
method and mean values of the resulting peak areas
and S/N ratios were used to compare the sensitivity
of IDA CNL and IDA thMRM.
Results and Discussion
Development of IDA Methods
A linear ion trap offers different scan modes to record a
product ion scan of each signal detected by the survey
scan. The intensities of both PreIS and CNL may be
similar when identical scan times are used. However,
precursor ion scan may be more sensitive compared to
a CNL if a dominant product ion is formed for the same
analyte and vice versa (i.e., if a dominant neutral loss
occurs such as loss of 162 Da for glycosides [25]). For
matrix samples (plasma or urine), a theoretically gen-
erated multiple reaction monitoring scan (thMRM) may
be even more sensitive compared to CNL and PreIS as
survey scans, because the noise level is significantly
reduced. This needs to be considered for the selection of
the type of survey scan applied to obtain highest
sensitivity and selectivity.
Based on these considerations, mass spectra of dif-
ferent thioethers of N-acetyl-L-cysteine were recorded
to obtain characteristic substructure fragmentation pat-
terns. In the negative-ion mode, all available standards
showed a CNL of 129 Da, resulting from the cleavage of
the thioether (Scheme 1).
In the positive-ion mode, a product ion of m/z 130
(the corresponding fragment that resulted from the
CNL in the negative-ion mode) and/or a CNL of 163 Da(the N-acetyl-L-cysteine moiety) was observed in the
product ion spectra of many of the standards (Scheme
1). However, a common fragment or a CNL did not
occur in the positive-ion mode. These observations are
consistent with the reported spectra of mercapturic
acids derived from styrene, 1,3-butadiene, acrolein,
diclofenac, valproic acid, and dopamine, where CNLs
of 129 Da occur in the negative-ion mode and a frag-
ment ion of m/z 130 is formed in the positive-ion mode
[8, 26 –30].
Several compound-specific parameters relevant to the
generation of mass spectra were optimized with “quanti-
tative optimization”. Declustering potential and collision
energy were varied from 21 to 76 V and from 8 to
28 V, respectively, for the available standards (Table 1).
To determine a common DP and CE for highest average
sensitivities for all standards, DP and CE were set from
10 to 30 V for CE and 30, 50, and 70 V for DP,
respectively. With a DP of 50 V and CE of 20 V, all
standards were detected with satisfying sensitivity. For
thMRM, the CNL of 129 Da was used to calculate theo-
retical transitions (i.e., m/z 200¡ 71).
Optimization of the HPLC Parameters for the MA-
Screening Method
The chromatographic separation should provide opti-
mized S/N ratios combined with high ionization effi-
ciency to achieve optimized sensitivity with LC-MS.
Ammonium acetate (5 mM, pH 6.8) was found to be the
optimal buffer to detect the standards with peak shapes
and separation efficiency with a full width at half
maximum (b1/2)  0.14 min on the RP-18-HPLC col-
umns used (Figure 1).
Comparison of Sensitivity
The LOD of each MA was different depending on the
Scheme 1. Fragmentation of the mercapturic acid of diclofenac by
collision induced dissociation (CID) in the negative and positive-
ion mode. The neutral loss (NL) of 129 Da in the negative-ion
mode was observed in all mercapturic acids tested so far. With
positive CID, diclofenac showed a fragment ion of 130 like other
standards, but did not show a CNL of 163 Da.chemical structure and ranged from 0.58 to 140 pmol on
ic aci
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450. The LOD in the MRM mode with one transition
optimized for each MA was 100- (N-acetyl-(4-bromo-
benzyl)-L-cysteine) to 4400-fold (N-acetyl-(1,1-dichloro-
2,2-difluoroethyl)-L-cysteine) lower than in the CNL
mode due to optimized parameters, noise reduction,
and an increase in scan time in the MRM mode.
However, for the detection of unknown MA, an
optimization is not possible. Therefore, methods were
developed with mass spectrometric and HPLC param-
eters applicable to analyze unknown MA with DP of
50 V and CE of 20 V. A mass range from m/z 200 to
450 was set for CNL and thMRM. CNL was compared
with IDA CNL, thMRM for 251 transitions (thMRM-
251) with IDA thMRM-251, respectively, with thMRM-
25. The CNL methods were compared with the corre-
sponding thMRM method to evaluate each method for
specificity and sensitivity. The S/N ratios were slightly
higher (1.2-fold) in CNL compared to IDA CNL and
1.3-fold higher in thMRM compared to IDA thMRM.
S/N ratios of thMRM-25 compared to S/N ratios of
thMRM-251 were about 5-fold higher. S/N ratios of
thMRM-251 compared to CNL were about 2-fold
higher. A comparison of CNL with a mass range of only
25 Da i.e., from m/z 200 to 225 with thMRM-25, was not
performed since the molecular masses of the standards
ranged from m/z 221 to 332 and showed a disadvantage
of the CNL scan (data not shown).
Compared to the data in MeOH/H2O, the LOD in
urine samples were comparable for both methods for 10
of the 12 standards. For N-acetyl-(1,2-dichlorovinyl)-L-
cysteine and N-acetyl-3-OH-propyl-L-cysteine, the LOD
was 5-fold lower in the IDA CNL and 2-fold lower in
Figure 1. LC-ESI-MS/MS chromatogram of a se
see Table 2), each with a concentration of 2.5
methoxybenzyl)-L-cysteine, spiked to rat urine
obtained with IDA CNL. Two of the mercapturthe IDA thMRM-251 compared to MeOH/H2O matrix(Table 2). For all standards, the IDA thMRM-251 was
equal to or up to 2-fold more sensitive as compared to
IDA CNL. In spiked samples from microsomal incuba-
tions, the LODs of the MA standards were in the same
range (from 2-fold lower to 5-fold higher) as described
for urine and MeOH/H2O samples (data not shown).
The mercapturic acid of acetaminophen was used to
determine the linearity with r2  0.997 (IDA CNL) and
r2  0.998 (IDA thMRM-251) in a dynamic range of 0.3
g/mL to 100 g/mL in rat urine samples.
In summary, both methods applied were equally
sensitive in all matrices tested. The different LOD for
the standards in different matrices may be explained by
the influence of the sample solvents containing buffers
and salts on the electrospray ionization of standards
eluting close to the solvent front (e.g., N-acetyl-(3-
hydroxypropyl)-L-cysteine with a retention time of 1.7
min; Figure 1).
Application of the Method to Detect Derivatives
of N-Acetyl-L-Cysteine in Biological Samples
Urine samples of rats not intentionally exposed to
xenobiotica were screened for the presence of mercap-
turic acids with both IDA methods. Over 50 signals in
the CNL 129 Da survey scan and the thMRM survey
scan, respectively, were observed (Figure 2). Intensity
varied form sample to sample. Product ion spectra of
the corresponding precursor ions were recorded. How-
ever, in all samples analyzed, a compound with the
[M  H]  mass of 320 Da was present (Figure 3a). The
product ion spectra (positive- and negative-ion mode,
tion of twelve mercapturic acid standards (1–12,
mL and an internal standard of N-acetyl-(4-
tion volume of 5 L). The chromatogram was
ds elute at tR  11.73 min.para
 g/
(injecFigure 3b and c) of this compound were identical to
0.
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droxynonene mercapturic acid. Hence, this compound
was identified as the mercapturic acid of 1,4-dihy-
droxynonene with [M  H] at 320 Da, an endogenous
metabolite of 4-hydroxynonenal formed during lipid
peroxidation [22, 31].
Diclofenac was chosen as a model substrate to test the
suitability of the analytical approach to detect mercapturic
acid formation from metabolites of xenobiotics formed by
microsomal oxidations. The structures of these derivatives
formed from diclofenac are known [30, 32]. In incubations
of diclofenac with microsomes from humans and rats in
the presence of N-acetyl-L-cysteine, two metabolites with
Table 2. LOD [g per mL] of standard mercapturic acids spiked
Detection of the signals by IDA CNL and IDA thMRM. The LOD
of at least three out of five product ion scans and giving a signal
Compounds
N-acetyl-(2,2-dichlorovinyl)-L-cysteine (1)
N-acetyl-(4-chlorobenzyl)-L-cysteine (2)
N-acetyl-(2-fluorobenzyl)-L-cysteine (3)
N-acetyl-(4-bromobenzyl)-L-cysteine (4)
N-acetyl-(4-tert-butylbenzyl)-L-cysteine (5)
3-(N-acetylcystein-S-yl)-acetaminophen (6)
N-acetyl-(1,1-Dichloro-2,2-difluoroethyl)-L-cysteine (7)
N-acetyl-phenyl-L-cysteine (8)
N-acetyl-(2,4-dinitrophenyl)-L-cysteine (9)
N-acetyl-(1,2,2-trichlorovinyl)-L-cysteine (10)
N-acetyl-(3-hydroxypropyl)-L-cysteine (11)
N-acetyl-(1,2-dichlorovinyl)-L-cysteine (12)
Figure 2. Comparison of total ion current (TIC
IDA thMRM (b) in control rat urine for the detec
Chromatogram of a selected mass is achievable by e[MH] ions atm/z 471 were detected by both IDA CNL
and IDA thMRM-251 analysis (Figure 4). By product ion
analysis, the signals with m/z 471 were identified as two
mercapturic acids of hydroxydiclofenac (data not shown).
The fragmentation of these ions resulted in the formation
of product ions atm/z 162 and 342. The fragment ion atm/z
162 was assigned to the N-acetyl-L-cysteine moiety,
whereas the fragment ion at m/z 342 resulted from the
neutral loss of 129 Da. The ion of m/z 298 was formed by
the combined loss of 129 and of 44 Da (CO2). The fragment
with m/z 262 is probably afforded by an additional loss of
HCl. In addition, the chlorine pattern could be used for
confirmation of the presence of a diclofenac metabolite.
at urine and to MeOH/H2O (50:50 vol./vol.), respectively.
defined as the concentration of analyte yielding the recording
ratio  3) with a CNL of 129 Da
D [g/mL] determined
with IDA CNL
LOD [g/mL] determined
with IDA MRM
rine MeOH/H2O Rat urine MeOH/H2O
04 0.04 0.02 0.02
02 0.04 0.02 0.02
04 0.04 0.04 0.04
02 0.02 0.02 0.02
02 0.02 0.02 0.02
42 0.42 0.21 0.42
10 0.21 0.10 0.21
04 0.02 0.04 0.02
02 0.02 0.02 0.02
10 0.21 0.10 0.21
21 0.83 0.10 0.21
42 2.08 0.42 0.83
omatograms of the methods IDA CNL (a) and
f endogenous and unknown mercapturic acids.to r
was
(S/N
LO
Rat u
0.
0.
0.
0.
0.
0.
0.
0.
0.
0.
0.) chr
tion oxtracting this mass from the TIC.
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Both IDA methods were applicable to all matrices
tested. One advantage of the IDA thMRM may be the
applicability of two different transitions typical for one
single analyte to trigger the recording of product ion
spectra (i.e., two different CNL, two different product
ions, or more probably the combination of a CNL and a
specific product ion). The possible disadvantage of
using non-optimized collision energies would be over-
come by the use of two different collision energies (e.g.,
by the addition of another experiment with a higher CE
to the method) to generate different mass spectra with
different fragment intensities (data not shown).
Moreover, dwell times have an influence on the
sensitivity of the thMRM method. Therefore, scanning
the masses with a dwell time higher than 5 ms will
result in a further increase in sensitivity. In tests, an
Figure 3. Extracted ion current (XIC) of ten ma
of a rat urine sample. The product ion spectra of
(b) and the corresponding mass of m/z 322 in th
Figure 4. Extracted ion current chromatogram
a mass of m/z 471 (and the isotope with m/z 2) obtaincrease of the dwell time to 15 ms already gave a 2-fold
higher S/N ratio. With an approximate knowledge-
based prediction of the metabolite of interest, the mass
window may be restricted, the dwell time may be
extended, and sensitivity may be increased as shown
for the comparison of IDA thMRM-251 and IDA
thMRM-25.
Conclusions
The presented data show the capabilities of modern
mass spectrometry for detection and identification of
analytes like mercapturic acids in complex matrices.
Both IDA methods, utilizing CNL or thMRM, show
similar sensitivity to screen for thioethers of N-acetyl-
L-cysteine in microsomal incubations or urine samples.
The slightly lower sensitivity of IDA methods com-
(m/z 315 to 324) in IDA CNL (a) in a separation
etabolite with m/z 320 in the negative-ion mode
sitive-ion mode (c).
o mercapturic acids of hydroxydiclofenac withsses
the mof tw
ined with IDA CNL (a) and IDA thMRM (b).
1983J Am Soc Mass Spectrom 2005, 16, 1976–1984 DETECTION OF MERCAPTURIC ACIDS BY LC-MS/MSpared to methods without IDA may be improved by a
more efficient sample preparation (i.e., sample enrich-
ment). However, the advantage of additional informa-
tion on chemical structure of the detected compounds
by IDA could be considered as more important com-
pared to the slightly higher sensitivity without IDA.
The presented methods may be applied to other
groups of analytes providing a CNL or a special prod-
uct ion that could be used for a precursor ion scan to
present a survey scan in a corresponding IDA method.
For example, DNA-modifications may be analyzed by
this MS-MS technique using the loss of 116 Da (i.e., for
etheno-dA or OTA-dG [33, 34]. The loss of 116 Da
corresponds to the desoxyribose moiety comparable to
the fragmentation described for glycosides by Qu et al.
[25]. Another fragment of sugar compounds is formed
by glucuronic acids (neutral loss of 176 Da) [6, 10].
IDA thMRM for known analytes may provide high
sensitivity combined with high specificity in analytical
methods. In one separation, an analyte can be quanti-
tated and identified by retention time, MRM, and stable
isotope labeled internal standard. Additional specificity
is gained by recording the corresponding characteristic
product ion mass spectrum of each signal detected by
the MRM scan. This has recently been shown for 301
drugs [14].
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